Stuttgart - Delayed Quote EUR

Blueprint Medicines Corp (2L9.SG)

Compare
107.90
-0.60
(-0.55%)
At close: January 31 at 9:34:02 PM GMT+1

Key Executives

Blueprint Medicines Corp

Description

Corporate Governance

Blueprint Medicines Corp’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

February 13, 2025 at 1:30 PM UTC - February 17, 2025 at 1:30 PM UTC

Blueprint Medicines Corp Earnings Date

Recent Events

Related Tickers